Sunday, April 17, 2005

new anti cancer medicine

Avastin (Bevacizumab) 是由美國Genentech公司所發展出來的新藥。它是將自老鼠身上所得對抗VEGF的單株抗體,利用基因工程的 ... 如此將Avastin注射到人體後,不會因為物種的不同而產生抗Avastiin的中和抗體。
Avastin, formerly known as anti-VEGF, is a potential inhibitor of VEGF, one ofthe key angiogenic factors that helps provide the blood supply, nutrients andoxygen enabling tumors to grow.
Avastin is the first US Food and DrugAdministration (FDA) approved therapy designed to inhibit angiogenesis, theprocess by which new blood vessels develop and carry vital nutrients to a tumor.
Avastin is a monoclonal antibody that works by attaching to and inhibitingthe action of vascular endothelial ... When VEGF is bound to Avastin, it cannotstimulate the formation and growth of new blood vessels (angiogenesis).

0 Comments:

Post a Comment

<< Home